Amgen’s $27.8 Billion Deal for Horizon Therapeutics Clears Key Hurdle
The Federal Trade Commission said it had agreed to end its legal challenge of the $27.8 billion deal. The pact...
HZNP
FTC Pauses Challenge to Amgen’s $27.8 Billion Deal for Horizon Therapeutics
The move gives the agency time to weigh a settlement that would allow the deal to close with conditions. Source...
FTC Moves to Block Amgen’s $27.8 Billion Deal for Horizon Therapeutics
ShareListen(2 min) Source link
Amgen Agrees to Deal to Buy Horizon Therapeutics
BusinessThe U.S. biotechnology company will pay $116.50 for each Horizon share Source link
